Search

Your search keyword '"Malyszko, Jolanta"' showing total 975 results
Start Over Author "Malyszko, Jolanta"
975 results on '"Malyszko, Jolanta"'

1. Improving the sustainability and quality of kidney health care through life cycle assessments, quality improvement, education and technical innovations: the KitNewCare approach

Author

Duane, Brett, Steinbach, Ingeborg, Stancliffe, Rachel, Barna, Stefi, Cameron, David, de Barbieri, Ilaria, Noruisiene, Edita, Mortimer, Frances, Gerritsen, Karin, Vanholder, Raymond, Donati, Gabriele, Alfano, Gaetano, Malyszko, Jolanta, Ligabue, Giulia, Johnston, Bridget, Wratten, Mary Louise, Caiazzo, Marialuisa, Schmid, Elisabeth, and Ortiz, Alberto

Published
2024
Full Text
View/download PDF

4. Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review

Author

Barbieri, Michelangela, Chiodini, Paolo, Di Gennaro, Piergiacomo, Hafez, Gaye, Liabeuf, Sophie, Malyszko, Jolanta, Mani, Laila-Yasmin, Mattace-Raso, Francesco, Pepin, Marion, Perico, Norberto, Simeoni, Mariadelina, Zoccali, Carmine, Tortorella, Giovanni, Capuano, Annalisa, Remuzzi, Giuseppe, Capasso, Giovambattista, and Paolisso, Giuseppe

Published
2024
Full Text
View/download PDF

14. Challenges in the management of the kidney allograft: from decline to failure: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Author

Ahn, Curie, Alberú, Josefina, Baliker, Mary, Bamgboye, Ebun L., Barber, Thelma, Bensouda, Melissa, Chadban, Steve J., Dadhania, Darshana M., Dębska-Ślizień, Alicja, Devresse, Arnaud, Ditzen, Beate, Fowler, Kevin, Gill, John S., Jha, Vivekanand, Khairallah, Pascale, Knoll, Greg A., Korst, Uwe, Lee, Austin, Legendre, Christophe, Lentine, Krista L., Lerma, Edgar V., Lorenz, Elizabeth C., Matas, Arthur J., Mohan, Sumit, Nazarewski, Sławomir, Noronha, Irene L., Obrador, Gregorio T., Parekh, Rulan S., Pavlakis, Martha, Pascual, Julio, Pilmore, Helen L., Rosenkranz, Alexander R., Rozen-Zvi, Benaya, Roy-Chaudhury, Prabir, Tanabe, Kazunari, Wanner, Christoph, Wasse, Haimanot, Yang, Chul-Woo, Josephson, Michelle A., Becker, Yolanda, Budde, Klemens, Kasiske, Bertram L., Kiberd, Bryce A., Loupy, Alexandre, Małyszko, Jolanta, Mannon, Roslyn B., Tönshoff, Burkhard, Cheung, Michael, Jadoul, Michel, Winkelmayer, Wolfgang C., and Zeier, Martin

Published
2023
Full Text
View/download PDF

15. Trends and perspectives for improving quality of chronic kidney disease care: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Author

Al-Aly, Ziyad, Ashuntantang, Gloria E., Boor, Peter, Calice da Silva, Viviane, Coleman, Jill, Coresh, Josef, Delanaye, Pierre, Ebert, Natalie, Enghard, Philipp, Feldman, Harold I., Fisher, Lori, Flythe, Jennifer E., Fukui, Akira, Grams, Morgan E., Ix, Joseph H., Jardine, Meg J., Jha, Vivek, Ju, Wenjun, Jurish, Robert, Kalyesubula, Robert, Kashihara, Naoki, Levey, Andrew S., Levin, Adeera, Luyckx, Valerie, Małyszko, Jolanta, Manski-Nankervis, Jo-Anne, Navaneethan, Sankar D., Obrador, Greg, Ortiz, Alberto, Ortiz, John, Cardoso Dos Santos, Bento Fortunato, Sarnak, Mark J., Schaeffner, Elke, Selby, Nick M., Simpson, David M., Solá, Laura, St. Peter, Wendy L., Stevens, Paul E., Tangri, Navdeep, Tannor, Elliot Koranteng, Tchokhonelidze, Irma, Wilck, Nicola, Wong, Michelle M.Y., Eckardt, Kai-Uwe, Delgado, Cynthia, Heerspink, Hiddo J.L., Pecoits-Filho, Roberto, Ricardo, Ana C., Stengel, Bénédicte, Tonelli, Marcello, Cheung, Michael, Jadoul, Michel, Winkelmayer, Wolfgang C., and Kramer, Holly

Published
2023
Full Text
View/download PDF

16. Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Author

Afsar, Baris, Akizawa, Tadao, Anker, Stefan D., Arici, Mustafa, Babitt, Jodie L., Barratt, Jonathan, Berns, Jeffrey S., Besarab, Anatole, Bhandari, Sunil, Brown, Christopher, Cases, Aleix, Chertow, Glenn M., Delgado, Cynthia, Drüeke, Tillman B., Fishbane, Steven, Gómez, Rafael, Grams, Morgan E., Hamano, Takayuki, Hao, Chuan-Ming, Hsu, Raymond K., Iseki, Kunitoshi, Jordans, Isabelle, Lerma, Edgar V., Locatelli, Francesco, Macdougall, Iain C., Małyszko, Jolanta, Maxwell, Patrick, McMahon, Lawrence P., Obrador, Gregorio T., Ostermann, Marlies, Pecoits-Filho, Roberto, Perwad, Farzana, Roger, Simon D., Singh, Ajay K., Solá, Laura, Spinowitz, Bruce S., Sugahara, Mai, Takahashi, Toshiyuki, Tanaka, Mototsugu, Tanaka, Tetsuhiro, Tarng, Der-Cherng, Tonelli, Marcello, Tsukamoto, Yusuke, Walther, Carl P., Yee-Moon Wang, Angela, Kong, Hong, Warady, Bradley A., Webster, Angela C., Weir, Matthew R., Wish, Jay B., Wong, Muh Geot, Ku, Elaine, Del Vecchio, Lucia, Eckardt, Kai-Uwe, Haase, Volker H., Johansen, Kirsten L., Nangaku, Masaomi, Tangri, Navdeep, Waikar, Sushrut S., Więcek, Andrzej, Cheung, Michael, Jadoul, Michel, Winkelmayer, Wolfgang C., and Wheeler, David C.

Published
2023
Full Text
View/download PDF

17. Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Author

Bagasha, Peace, Bargman, Joanne M., Bavanandan, Sunita, Beckwith, Hannah, Bennett, Paul N., Bohm, Clara, Brennan, Frank, Burton, James O., Cavanaugh, Kerri L., Chilcot, Joseph, Choi, Peter, Cukor, Daniel, Dember, Laura M., Dong, Jie, Edwards, Dawn, Erickson, Kevin F., Figueiredo, Ana, Finkelstein, Fredric O., Fukagawa, Masafumi, Germain, Michael, Guillano, Franklin B., Hurst, Helen, Iseki, Kunitoshi, Jardine, Meg J., Jauré, Allison, Jha, Vivekanand, Jhamb, Manisha, Kanjanabuch, Talerngsak, Lerma, Edgar, Kam-Tao Li, Philip, Liew, Adrian, Małyszko, Jolanta, Proenca de Moraes, Thyago, Moranne, Olivier, Nam Ng, Marques Shek, Ostermann, Marlies, Perl, Jeffrey, Pigford, Jayne, Pommer, Wolfgang, Richardson, Michelle M., Rivara, Matthew B., Roberts, Glenda V., Sarafidis, Pantelis, Shroff, Rukshana, Slon Roblero, Maria Fernanda, Smyth, Brendan, Søndergaard, Henning, Van Der Veer, Sabine N., Vassalotti, Joseph A., Vervloet, Marc, Vincent, Lloyd, Walker, Rachael, Warren, Madeleine, Wasylynuk, Betty Ann, West, Melissa, Wilkie, Caroline, Mehrotra, Rajnish, Davison, Sara N., Farrington, Ken, Flythe, Jennifer E., Foo, Marjorie, Madero, Magdalena, Morton, Rachael L., Tsukamoto, Yusuke, Unruh, Mark L., Cheung, Michael, Jadoul, Michel, Winkelmayer, Wolfgang C., and Brown, Edwina A.

Published
2023
Full Text
View/download PDF

18. Scope and Consistency of Cancer Outcomes Reported in Randomized Trials in Kidney Transplant Recipients

Author

Au, Eric H., Wong, Germaine, Tong, Allison, Teixeira-Pinto, Armando, van Zwieten, Anita, Dobrijevic, Ellen, Ahn, Curie, Blosser, Christopher D., Davidson, Bianca, Francis, Anna, Jhaveri, Kenar D., Malyszko, Jolanta, Mena-Gutierrez, Alejandra, Newell, Kenneth A., Palmer, Sarah, Scholes-Robertson, Nicole, Silva Junior, Helio Tedesco, and Craig, Jonathan C.

Published
2023
Full Text
View/download PDF

28. International Nephrology Masterclass in Chronic Kidney Disease: Rationale, Summary, and Future Perspectives.

Author

Pesce, Francesco, Vadalà, Maria, Almeida, Edgar, Fernandez, Beatriz, Fouque, Denis, Malyszko, Jolanta, Schmidt-Ott, Kai, Stenvinkel, Peter, Wheeler, David C., Seidu, Samuel, Cebrian, Ana, Dimov, Nikolay, Pardo, Marta Blanco, Ziedina, Ieva, Habashi, Nayaf, Manrique, Joaquin, Marques, Sofia Homem De Melo, Gallardo, Marco Antonio Vaca, Shehaj, Larisa, and Nikolova Vlahova, Milena Krasimirova

Subjects
SEX factors in disease, CHRONIC kidney failure, GENETICS, NEPHROLOGY, DIABETES, COMORBIDITY
Abstract

Chronic kidney disease (CKD) is a progressive condition that affects more than 10% of the population worldwide, accounting for more than 843 million (M) individuals. The prevalence of CKD (844 M patients) is higher than that of diabetes mellitus (422 M patients), cancer (42 M patients), and HIV (37 M patients), but people are often less aware of it. Global expert groups predict reductions in the nephrology workforce in the next decade, with a declining interest in nephrology careers. Over time, KDIGO guidelines have also focused on topics related to the prevention or management of CKD patients in real-life settings. On these premises, a new educational program with international experts in the field of nephrology took place from November 2022 until March 2023 in Milan, Italy. This multinational masterclass provided an educational platform providing unbiased education on diagnosis and treatment by sharing the most recent research data on CKD and comorbidities, therefore creating a snowball effect to increase the implementation of best practices worldwide, using examples from 'real-life' patient outcomes. This paper provides an overview of the International Nephrology Masterclass (INM) concept, summarizing the key lectures and discussions, and giving an outline of future key developments. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

29. Cancer therapy in patients with reduced kidney function.

Author

Karam, Sabine, Rosner, Mitchell H, Sprangers, Ben, Stec, Rafal, and Malyszko, Jolanta

Subjects
RENAL replacement therapy, IMMUNE checkpoint inhibitors, RENAL cancer, NEPHROTOXICOLOGY, KIDNEY physiology
Abstract

Chronic kidney disease (CKD) and cancer constitute two major public health burdens, and both are on the rise. Moreover, the number of patients affected simultaneously by both conditions is growing. The potential nephrotoxic effect of cancer therapies is particularly important for patients with CKD, as they are also affected by several comorbidities. Therefore, administering the right therapy at the right dose for patients with decreased kidney function can represent a daunting challenge. We review in detail the renal toxicities of anticancer therapies, i.e. conventional chemotherapy, targeted therapy, immune checkpoint inhibitors and radioligand therapies, issue recommendations for patient monitoring along with guidance on when to withdraw treatment and suggest dosage guidelines for select agents in advanced stage CKD. Various electrolytes disturbances can occur as the result of the administration of anticancer agents in the patient with decreased kidney function. These patients are prone to developing hyponatremia, hyperkalemia and other metabolic abnormalities because of a decreased glomerular filtration rate. Therefore, all electrolytes, minerals and acid base status should be checked at baseline and before each administration of chemotherapeutic agents. Moreover, studies on patients on kidney replacement therapy are very limited and only single cases or small case series have been published. Therefore, clinical therapeutical decisions in cancer patients with decreased function should be made by multidisciplinary teams constituted of medical oncologists, nephrologists and other specialists. Onconephrology is an evolving and expanding subspecialty. It is crucial to consider anticancer drug treatment in these patients and offer them a chance to be treated effectively. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

30. Can Novel Biomarkers Effectively Predict Acute Kidney Injury in Liver or Kidney Transplant Recipients?

Author

Zywno, Hubert, Figiel, Wojciech, Grat, Michal, Nazarewski, Slawomir, Galazka, Zbigniew, and Malyszko, Jolanta

Subjects
ACUTE kidney failure, CHRONIC kidney failure, LIVER transplantation, GLOMERULAR filtration rate, KIDNEY transplantation
Abstract

Acute kidney injury (AKI) constitutes a common complication associated with liver or kidney transplantation, which may significantly impact the graft condition and perioperative mortality. Current AKI diagnostic criteria based on serum creatinine (sCr) and urine output alterations are widely utilized in routine clinical practice. However, the diagnostic value of sCr may be limited by various confounding factors, including age, sex, reduced or increased muscle mass, and pre-existing chronic kidney disease (CKD). Furthermore, sCr is rather a late indicator of AKI, as its concentration tends to increase only when the severity of the injury is enough to decrease the estimated glomerular filtration rate (eGFR). Recent expertise highlights the need for novel biomarkers in post-transplantation AKI diagnosis, prediction of event-associated mortality, or evaluation of indications for renal replacement treatment (RRT). Over the last decade, the diagnostic performance of various AKI biomarkers has been assessed, among which some showed the potential to outperform sCr in AKI diagnosis. Identifying susceptible individuals, early diagnosis, and prompt intervention are crucial for successful transplantation, undisturbed graft function in long-term follow-up, and decreased mortality. However, the research on AKI biomarkers in transplantation still needs to be explored. The field lacks consistent results, rigorous study designs, and external validation. Considering the rapidly growing prevalence of CKD and cirrhosis that are associated with the transplantation at their end-stage, as well as the existing knowledge gap, the aim of this article was to provide the most up-to-date review of the studies on novel biomarkers in the diagnosis of post-transplantation AKI. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

32. Nephrology in Poland

Author

Lichodziejewska-Niemierko, Monika, Czerwiński, Jarosław, Dębska-Ślizień, Alicja, Gellert, Ryszard, Grenda, Ryszard, Małyszko, Jolanta, Naumnik, Beata, Nowicki, Michał, Ostrowski, Janusz, Więcek, Andrzej, Moura-Neto, José A., editor, Divino-Filho, José Carolino, editor, and Ronco, Claudio, editor

Published
2021
Full Text
View/download PDF

37. Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference

Author

Caskey, Fergus J., Farmer, Chris K.T., Ferreiro Fuentes, Alejandro, Fukagawa, Masafumi, Goldstein, Stuart L., Igiraneza, Grace, Kribben, Andreas, Lerma, Edgar V., Levey, Andrew S., Liu, Kathleen D., Małyszko, Jolanta, Ostermann, Marlies, Pannu, Neesh, Ronco, Claudio, Sawhney, Simon, Shaw, Andrew D., Srisawat, Nattachai, Lameire, Norbert H., Levin, Adeera, Kellum, John A., Cheung, Michael, Jadoul, Michel, Winkelmayer, Wolfgang C., and Stevens, Paul E.

Published
2021
Full Text
View/download PDF

38. Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Author

Ademi, Zanfina, Chang, Tara I., Clark, Tim, Cooper, Chris, Criqui, Michael, de Bhailis, Áine, De Carlo, Marco, Döhner, Wolfram, Engelman, Daniel T., Fowkes, Gerry, Green, Darren, Hamdan, Allen, Heiss, Christian, Huppert, Peter, Kadian-Dodov, Daniella, Lip, Gregory Y.H., Małyszko, Jolanta, Mark, Patrick B., Miglinas, Marius, Murray, Patrick, Reid, Chris, Rochon, Paul, Ruturi, Josiah, Saratzis, Athanasios, Sarnak, Mark J., Shanahan, Cathy M., Solá, Laura, Teichgräber, Ulf, Textor, Stephen C., Toyoda, Kazunori, Yee-Moon Wang, Angela, Wong, Chris X., Johansen, Kirsten L., Garimella, Pranav S., Hicks, Caitlin W., Kalra, Philip A., Kelly, Dearbhla M., Martens, Sven, Matsushita, Kunihiro, Sarafidis, Pantelis, Sood, Manish M., Herzog, Charles A., Cheung, Michael, Jadoul, Michel, Winkelmayer, Wolfgang C., and Reinecke, Holger

Published
2021
Full Text
View/download PDF

39. Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference

Author

Abu-Alfa, Ali K., Afsar, Baris, Pai, Amy Barton, Besarab, Anatole, Moore, Geraldine Biddle, Casadevall, Nicole, Cases, Aleix, de Francisco, Angel, Eckardt, Kai-Uwe, Fishbane, Steven, Fried, Linda F., Ganz, Tomas, Ginzburg, Yelena Z., Gómez, Rafael, Goodnough, Lawrence T., Hamano, Takayuki, Hanudel, Mark R., Hao, Chuan-Ming, Iseki, Kunitoshi, Ix, Joachim H., Johansen, Kirsten L., Ketteler, Markus, Kovesdy, Csaba P., Leaf, David E., Macdougall, Iain C., Massy, Ziad A., McMahon, Lawrence P., Minutolo, Roberto, Nakanishi, Takeshi, Nemeth, Elizabeta, Obrador, Gregorio T., Parfrey, Patrick S., Park, Hyeong-Cheon, Pecoits-Filho, Roberto, Robinson, Bruce M., Roger, Simon D., Shah, Yatrik M., Spinowitz, Bruce S., Tanaka, Tetsuhiro, Tsukamoto, Yusuke, Tungsanga, Kriang, Walther, Carl P., Yee-Moon Wang, Angela, Wolf, Myles, Babitt, Jodie L., Eisenga, Michele F., Haase, Volker H., Kshirsagar, Abhijit V., Levin, Adeera, Locatelli, Francesco, Małyszko, Jolanta, Swinkels, Dorine W., Tarng, Der-Cherng, Cheung, Michael, Jadoul, Michel, Winkelmayer, Wolfgang C., and Drüeke, Tilman B.

Published
2021
Full Text
View/download PDF

41. Range and Consistency of Cardiovascular Outcomes Reported by Clinical Trials in Kidney Transplant Recipients: A Systematic Review

Author

Wilson, Gregory J., Van, Kim, O’Lone, Emma, Tong, Allison, Craig, Jonathan C., Sautenet, Benedicte, Budde, Klemens, Forfang, Derek, Gill, John, Herrington, William G., Jafar, Tazeen H., Johnson, David W., Krane, Vera, Levin, Adeera, Malyszko, Jolanta, Rossignol, Patrick, Sawinski, Deirdre, Scholes-Robertons, Nicole, Strippoli, Giovanni, Wang, Angela, Winkelmayer, Wolfgang C., Hawley, Carmel M., and Viecelli, Andrea K.

Published
2023
Full Text
View/download PDF

44. Drugs with a negative impact on cognitive functions (part 3): antibacterial agents in patients with chronic kidney disease.

Author

Liabeuf, Sophie, Hafez, Gaye, Pešić, Vesna, Spasovski, Goce, Bobot, Mickaël, Mačiulaitis, Romaldas, Bumblyte, Inga Arune, Ferreira, Ana Carina, Farinha, Ana, Malyszko, Jolanta, Pépin, Marion, Massy, Ziad A, Unwin, Robert, Capasso, Giovambattista, Mani, Laila-Yasmin, and Target), CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative

Subjects
DRUG side effects, DRUG utilization, DRUG monitoring, CHRONIC kidney failure, CENTRAL nervous system
Abstract

The relationship between chronic kidney disease (CKD) and cognitive function has received increased attention in recent years. Antibacterial agents (ABs) represent a critical component of therapy regimens in patients with CKD due to increased susceptibility to infections. Following our reviewing work on the neurocognitive impact of long-term medications in patients with CKD, we propose to focus on AB-induced direct and indirect consequences on cognitive function. Patients with CKD are predisposed to adverse drug reactions (ADRs) due to altered drug pharmacokinetics, glomerular filtration decline, and the potential disruption of the blood–brain barrier. ABs have been identified as a major cause of ADRs in vulnerable patient populations. This review examines the direct neurotoxic effects of AB classes (e.g. beta-lactams, fluoroquinolones, aminoglycosides, and metronidazole) on the central nervous system (CNS) in patients with CKD. We will mainly focus on the acute effects on the CNS associated with AB since they are the most extensively studied effects in CKD patients. Moreover, the review describes the modulation of the gut microbiota by ABs, potentially influencing CNS symptoms. The intricate brain–gut–kidney axis emerges as a pivotal focus, revealing the interplay between microbiota alterations induced by ABs and CNS manifestations in patients with CKD. The prevalence of antibiotic-associated encephalopathy in patients with CKD undergoing intravenous AB therapy supports the use of therapeutic drug monitoring for ABs to reduce the number and seriousness of ADRs in this patient population. In conclusion, elucidating AB-induced cognitive effects in patients with CKD demands a comprehensive understanding and tailored therapeutic strategies that account for altered pharmacokinetics and the brain–gut–kidney axis. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

45. KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantation

Author

Abu-Alfa, Ali K., Amer, Hatem, Beutel, Gernot, Chapman, Jeremy, Chen, Xiaohong, Chudek, Jerzy, Cosmai, Laura, Danesi, Romano, De Stefano, Filippo, Iseki, Kunitoshi, Jaimes, Edgar A., Jhaveri, Kenar D., Jurczyszyn, Artur, Kazancioğlu, Rümeyza, Kitchlu, Abhijat, Kollmannsberger, Christian, Lahoti, Amit, Li, Yang, Macía, Manuel, Matsubara, Takeshi, Mitropoulos, Dionysios, Noiri, Eisei, Perazella, Mark A., Ronco, Pierre, Rosner, Mitchell H., Soler Romeo, Maria Jose, Sprangers, Ben, Stadler, Walter M., Stevens, Paul E., Tesař, Vladimír, Torres da Costa e Silva, Verônica, Vesole, David H., Vijayan, Anitha, Viklický, Ondřej, Workeneh, Biruh T., Yanagita, Motoko, Zakharova, Elena, Małyszko, Jolanta, Bamias, Aristotelis, Danesh, Farhad R., Dębska-Ślizień, Alicja, Gallieni, Maurizio, Gertz, Morie A., Kielstein, Jan T., Tesarova, Petra, Wong, Germaine, Cheung, Michael, Wheeler, David C., Winkelmayer, Wolfgang C., and Porta, Camillo

Published
2020
Full Text
View/download PDF

47. KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer

Author

Abu-Alfa, Ali K., Amer, Hatem, Beutel, Gernot, Chapman, Jeremy, Chen, Xiaohong, Chudek, Jerzy, Cosmai, Laura, Danesi, Romano, De Stefano, Filippo, Iseki, Kunitoshi, Jaimes, Edgar A., Jhaveri, Kenar D., Jurczyszyn, Artur, Kazancioğlu, Rümeyza, Kitchlu, Abhijat, Kollmannsberger, Christian, Lahoti, Amit, Li, Yang, Macía, Manuel, Matsubara, Takeshi, Mitropoulos, Dionysios, Noiri, Eisei, Perazella, Mark A., Ronco, Pierre, Rosner, Mitchell H., Soler Romeo, Maria Jose, Sprangers, Ben, Stadler, Walter M., Stevens, Paul E., ladimír Tesař, Torres da Costa e Silva, Verônica, Vesole, David H., Vijayan, Anitha, Viklický, Ondřej, Workeneh, Biruh T., Yanagita, Motoko, Zakharova, Elena, Porta, Camillo, Bamias, Aristotelis, Danesh, Farhad R., Dębska-Ślizień, Alicja, Gallieni, Maurizio, Gertz, Morie A., Kielstein, Jan T., Tesarova, Petra, Wong, Germaine, Cheung, Michael, Wheeler, David C., Winkelmayer, Wolfgang C., and Małyszko, Jolanta

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results